1-20 of 55
Wally R. Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rethinking Caseloads in Sickle Cell Disease Social Work

Spencer Moorman, Shirley Johnson, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 7963.
https://doi.org/10.1182/blood-2024-212283
Published: 2024
Journal Articles

“It Was Bootstrap All the Way”: Exploring the Barriers and Facilitators to the Development of Non-Hematology Sickle Cell Disease Experts in the United States

Francis W Coyne, Deirdra R Terrell, Valerie Lang, Ashley M Jenkins, Allison A. King, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 5202.
https://doi.org/10.1182/blood-2024-203728
Published: 2024
Journal Articles

Planning Mental Health and Social Support Prescreening Assessments for Adult Sickle Cell Disease Patients: Evaluating Readiness for Curative Therapy

Shirley Johnson, Haylee Hartzog, Cecelia R. Valrie, Yue May Zhang, Andrea Burton, Katrina Dalton, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 7654.
https://doi.org/10.1182/blood-2024-200954
Published: 2024
Journal Articles

Effect of Whole-Brain and Regional Silent Cerebral Ischemia on Pain and Cognition Among Adults with Sickle Cell Disease

Daniel M Sop, Yue May Zhang, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 5305.
https://doi.org/10.1182/blood-2024-199323
Published: 2024
Journal Articles

Enhanced Pain Sensitivity in Adult Sickle Cell Disease Patients: Potential Mediating Factors

Daniel M Sop, Yue May Zhang, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 5332.
https://doi.org/10.1182/blood-2024-199317
Published: 2024
Journal Articles

Cerebral Blood Flow and Pain Perception in Sickle Cell Disease: A Mediation Analysis

Daniel M Sop, Yue May Zhang, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 5339.
https://doi.org/10.1182/blood-2024-199307
Published: 2024
Journal Articles

Case Management Time in SCD Adults Is Correlated with ED and Ambulatory Utilization and with Behavioral Health Diagnoses, but Not with Hospitalization and Costs

Wally R Smith, Yue May Zhang, Andrea Burton, Shirley Johnson, Daniel M Sop
Journal: Blood
Blood (2024) 144 (Supplement 1): 2238.
https://doi.org/10.1182/blood-2024-200970
Published: 2024
Journal Articles

Comparative Analysis of Whole-Brain and Regional Cerebral Blood Flow, Pain Expression, Pain Sensitivity, and Cognitive Function in Adults with Sickle Cell Disease Versus Healthy Controls

Daniel M Sop, Yue May Zhang, Wally R Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 2494.
https://doi.org/10.1182/blood-2024-199327
Published: 2024
Journal Articles

Sickle Pain-Related Impact (SPiRIt): A Prospective Study of Impact of Chronic Pain in Sickle Cell Disease

Ashna Jagtiani, Cynthia Sinha, Ashleigh Hawk, Scott Gillespie, Mona Mirbeyk, Fuad El Rassi, Wally R Smith, Lakshmanan Krishnamurti, Soumitri Sil, Nitya Bakshi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3899.
https://doi.org/10.1182/blood-2024-210575
Published: 2024
Journal Articles

Comparing Emergency Department and Infusion Clinic Outcomes Among Individuals with Sickle Cell Disease Seeking Care for Vaso-Occlusive Crises

Joshua C. Laperche, Alka Apudhyay, Michelle Eakin, Alexander A Boucher, Laura M. DeCastro, Stephanie H. Guarino, Robert Kribs, Wally R Smith, Vannesia Morgan-Smith, Andrew RW O'Brien, Ashley Lauriello, Jane A. Little, Charlene Sylvestre, Sophie Lanzkron
Journal: Blood
Blood (2024) 144 (Supplement 1): 5062.
https://doi.org/10.1182/blood-2024-208270
Published: 2024
Journal Articles

What Interval of Daily Pain Assessment Is Required to Reliably Diagnose Chronic Pain in Sickle Cell Disease? the Pisces Study

Wally R Smith, Donna McClish
Journal: Blood
Blood (2023) 142 (Supplement 1): 252.
https://doi.org/10.1182/blood-2023-178065
Published: 2023
Journal Articles

A Patient-Centric Approach to Sickle Cell Disease Clinical Trials: Integrating Patient Perspectives in the RISE UP Phase 2/3 Trial of Mitapivat for Informed Protocol Design and Associated Patient Community Benefit

Charles R. Jonassaint, Blaze Armon Eppinger, Dominique Friend, Golie Lorenzo Green, Mia Robinson, Teonna Woolford, DeMitrious Wyant, Janie Davis, Abdulafeez Oluyadi, Ahmar U Zaidi, Holly John, Wally R Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 2376.
https://doi.org/10.1182/blood-2023-186710
Published: 2023
Journal Articles

Incidence, Prevalence, and Disease Management Impactability of High Utilization in an Adult Sickle Cell Medical Home

Wally R Smith, Daniel Sop, Yue May Zhang, Benjamin Jaworowski, Shirley Johnson
Journal: Blood
Blood (2023) 142 (Supplement 1): 7206.
https://doi.org/10.1182/blood-2023-187621
Published: 2023
Journal Articles

Component-Specific Effects of Team Case Management on Adult Sickle Cell Utilization in Moderate to Low Utilizers

Shirley Johnson, Daniel Sop, Austin Hardy, Rachel Walls, Yue May Zhang, Benjamin Jaworowski, Wally R Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 7197.
https://doi.org/10.1182/blood-2023-187590
Published: 2023
Journal Articles

Towards an Implicit Measure of Patient Engagement in Sickle Cell Disease: Relationships between Implicit Measures of Engagement and Previous Childhood Trauma Among Adolescents and Young Adults

Haylee Hartzog, Shirley Johnson, Rachel Walls, Yue May Zhang, Daniel Sop, Wally R Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 7319.
https://doi.org/10.1182/blood-2023-187552
Published: 2023
Journal Articles

Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study

Miguel R Abboud, Rodolfo D Cançado, Mariane De Montalembert, Wally R Smith, Hala Rimawi, Ersi Voskaridou, Birol Guvenc, Deborah Keefe, Kai Grosch, Michele L Nassin, Jimmy Watson, Justin Yssel, Evgeniya Reshetnyak, Yvonne Dei Adomakoh
Journal: Blood
Blood (2023) 142 (Supplement 1): 272.
https://doi.org/10.1182/blood-2023-185429
Published: 2023
Journal Articles

A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study of Mitapivat in Patients with Sickle Cell Disease: RISE UP Phase 2 Results

Modupe Idowu, Lucas Otieno, Bogdan Dumitriu, Clarisse LC Lobo, Swee Lay Thein, Biree Andemariam, Obiageli E Nnodu, Adlette Inati, Alexander K Glaros, Sara Teresinha Olalla Saad, Pablo Bartolucci, Raffaella Colombatti, Ali T Taher, Miguel R Abboud, Abdulafeez Oluyadi, Varsha Iyer, Ophelia Yin, Susan Morris, Amber M Yates, Hui Shao, Spurthi Patil, Rolandas Urbstonaitis, Ahmar U Zaidi, Wally R Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 271.
https://doi.org/10.1182/blood-2023-187033
Published: 2023
Journal Articles

Quality of Care Among Emerging Adults with Sickle Cell Disease Using the Ascq-ME Qoc Measure: Baseline ST3P-up Study Data Results

Ifeyinwa Osunkwo, Myra Robinson, Anya Griffin, Azizi Coleman, Sharvil Desai, Padmaja Veeramreddy, Payal Desai, Charity Patterson, James Symanowski, Paulette Bryant, Jennifer Cornette, Wally R Smith, James R Eckman, Ramona Lawrence
Journal: Blood
Blood (2023) 142 (Supplement 1): 5048.
https://doi.org/10.1182/blood-2023-186835
Published: 2023
Journal Articles

Relative Influence of Biological Versus Behavioral Determinants of Utilization Among Adults with Sickle Cell Disease

Mica Ferlis, Daniel Sop, Yue May Zhang, Wally R Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 3680.
https://doi.org/10.1182/blood-2023-187483
Published: 2023
Journal Articles

Intensive Case Management in an Adult Sickle Cell Medical Home: Annual Effects on Utilization Efficiency Using Community Health Workers

Shirley Johnson, Daniel M Sop, Yue May Zhang, Benjamin Jaworowski, Wally R Smith
Journal: Blood
Blood (2022) 140 (Supplement 1): 1625–1626.
https://doi.org/10.1182/blood-2022-169193
Published: 2022